InsiderTrades

Form 4 for CC Chemours Co

Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-02 · accession 0001627223-21-000052 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-12-03 2021-12-02 CC Ralhan Sameer SVP, CFO M - OptEx $18.45 +17.5K 316.6K +6% +$322.5K
D 2021-12-03 2021-12-02 CC Ralhan Sameer SVP, CFO S - Sale+OE $29.85 -17.5K 299.1K -6% -$521.8K
D 2021-12-03 2021-12-02 CC Ralhan Sameer SVP, CFO M - OptEx $0.00 -17.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-02 M A 17,482 $18.45 316,631.91 D — — (F2) Includes directly owned shares, restricted stock units, and dividend equivalent units.
2 Common Common Stock 2021-12-02 S D 17,482 $29.85 299,149.91 D — — (F3) Shares were sold in multiple transactions at prices ranging from $29.55 to $30.08. (F2) Includes directly owned shares, restricted stock units, and dividend equivalent units.
3 Derivative Stock Option (Right to Buy) 2021-12-02 M D 17,482 $0.00 0 D $18.45 · — to 2022-02-03 17,482 Common Stock (F4) Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016.